Bharate; Sandip Bibishan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bharate; Sandip Bibishan.The latest application filed is for "solid dispersion comprising an anticancer compound for improved solubility and efficacy".

Company Profile

5.6.10

Bharate; Sandip Bibishan - Jammu IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Gastroretentive sustained release formulations of Bergenia ciliata Grant 11,446,346 - Bharate , et al. September 20, 2	2022-09-20
Solid Dispersion Comprising An Anticancer Compound For Improved Solubility And Efficacy App 20210308116 - BHARATE; Sonali Sandip ; et al.	2021-10-07
Furanochalcones As Inhibitors Of Cyp1a1, Cyp1a2 And Cyp1b1 For Cancer Chemoprevention App 20210284618 - Bharate; Sandip Bibishan ; et al.	2021-09-16
Sustained Release Formulations Of Dysoxylum Binefacterum App 20210137841 - BHARATE; Sonali Sandip ; et al.	2021-05-13
Sustained Release Formulations Of Crocus Sativus App 20200390843 - BHARATE; Sonali Sandip ; et al.	2020-12-17
Gastroretentive Sustained Release Formulations Of Bergenia Ciliata App 20200316150 - Bharate; Sonali Sandip ; et al.	2020-10-08
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof Grant 10,696,688 - Bharate , et al. June 30, 2	2020-06-30
Fused Pyrimidines As Isoform Selective Phosphoinositide-3-kinase-alpha Inhibitors And Process For Preparation Thereof App 20200031845 - BHARATE; Sandip Bibishan ; et al.	2020-01-30
6-aryl-4-phenylamino-quinazoline analogs as phosphoinositide-3-kinase inhibitors Grant 10,202,374 - Vishwakarma , et al. Feb	2019-02-12
Pharmaceutical composition for the treatment of multi-drug resistant infections Grant 10,064,840 - Vishwakarma , et al. September 4, 2	2018-09-04
Tetrahydro-2H-pyrano[3,2-C]isochromene-6-ones and analogs for the treatment of inflammatory disorders Grant 9,777,014 - Jain , et al. October 3, 2	2017-10-03
Chromone alkaloid dysoline for the treatment of cancer and inflammatory disorders Grant 9,776,989 - Vishwakarma , et al. October 3, 2	2017-10-03
A Pharmaceutical Composition For The Treatment Of Multi-drug Resistant Infections App 20170273939 - VISHWAKARMA; Ram ; et al.	2017-09-28
6-aryl-4-phenylamino-quinazoline Analogs As Phosphoinositide-3-kinase Inhibitors App 20170015662 - Vishwakarma; Ram Asrey ; et al.	2017-01-19
Tetrahydro-2h-pyrano[3,2-c]isochromene-6-ones And Analogs For The Treatment Of Inflammatory Disorders App 20160122360 - Jain; Shreyans Kumar ; et al.	2016-05-05
Novel Chromone Alkaloid Dysoline For The Treatment Of Cancer And Inflammatory Disorders App 20160046611 - Vishwakarma; Ram Asrey ; et al.	2016-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.